ATE103180T1 - Impfstoff-zubereitung. - Google Patents

Impfstoff-zubereitung.

Info

Publication number: ATE103180T1
Authority: AT; Austria
Prior art keywords: canine coronavirus; vaccine preparation; attenuated; intestines; dogs
Prior art date: 1983-06-15

Application number

AT89202001T

Other languages

English (en)

Inventor

William Marshall Acree

Bobby Edwards

John Wesley Black

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-06-15

Filing date

1989-07-31

Publication date

1994-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27054825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE103180(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1983-06-15 Priority claimed from US06/504,434 external-priority patent/US4567043A/en

1989-07-31 Application filed by American Home Prod filed Critical American Home Prod

1994-04-15 Application granted granted Critical

1994-04-15 Publication of ATE103180T1 publication Critical patent/ATE103180T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

AT89202001T 1983-06-15 1989-07-31 Impfstoff-zubereitung. ATE103180T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US06/504,434 US4567043A (en)	1983-06-15	1983-06-15	Canine corona virus vaccine
US06/618,638 US4567042A (en)	1983-06-15	1984-06-07	Inactivated canine coronavirus vaccine
EP84902632A EP0145783B2 (de)	1983-06-15	1984-06-14	Impfstoff gegen hundecoronavirus

Publications (1)

Publication Number	Publication Date
ATE103180T1 true ATE103180T1 (de)	1994-04-15

Family

ID=27054825

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
AT84902632T ATE50913T1 (de)	1983-06-15	1984-06-14	Impfstoff gegen hundecoronavirus.
AT89201996T ATE280217T1 (de)	1983-06-15	1984-06-14	Hundecoronavirus
AT89201017T ATE103181T1 (de)	1983-06-15	1989-04-20	Tieraerztliche impfstoffe.
AT89202001T ATE103180T1 (de)	1983-06-15	1989-07-31	Impfstoff-zubereitung.

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
AT84902632T ATE50913T1 (de)	1983-06-15	1984-06-14	Impfstoff gegen hundecoronavirus.
AT89201996T ATE280217T1 (de)	1983-06-15	1984-06-14	Hundecoronavirus
AT89201017T ATE103181T1 (de)	1983-06-15	1989-04-20	Tieraerztliche impfstoffe.

Country Status (7)

Country	Link
US (1)	US4567042A (de)
EP (4)	EP0345911B1 (de)
AT (4)	ATE50913T1 (de)
DE (4)	DE3486293T3 (de)
ES (1)	ES8604422A1 (de)
NL (1)	NL940017I2 (de)
WO (1)	WO1985000014A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4990367A (en) *	1987-03-09	1991-02-05	Diamond Scientific Company	Canine distemper virus vaccine
US5565209A (en) *	1987-03-17	1996-10-15	Akzo Nobel N.V.	Adjuvant mixture
ZA881694B (en) *	1987-03-17	1988-09-06	Akzo N.V.	Adjuvant mixture
US4904468A (en) *	1987-06-08	1990-02-27	Norden Laboratories, Inc.	Canine coronavirus vaccine
US5911999A (en) *	1987-09-28	1999-06-15	Pfizer, Inc.	Vaccine based on TGEV for protection of dogs against canine coronavirus
US5232694A (en) *	1989-05-03	1993-08-03	Akzo N.V.	Canine corona virus vaccine
US5672350A (en) *	1989-08-22	1997-09-30	Veterinary Infectious Disease Organization	Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US6004563A (en) *	1990-11-07	1999-12-21	American Home Products Corporation	Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US6372224B1 (en)	1990-11-14	2002-04-16	Pfizer Inc.	Canine coronavirus S gene and uses therefor
US6057436A (en) *	1990-11-14	2000-05-02	Pfizer Inc.	Canine coronavirus S gene and uses therefor
ES2213743T3 (es) *	1991-04-25	2004-09-01	Akzo Nobel N.V.	Vacuna de subunidad de coronavirus canino.
US5750112A (en) *	1993-02-26	1998-05-12	Solvay Animal Health, Inc.	Canine coronavirus vaccine from feline enteric coronavirus
US20040053208A1 (en) *	1995-08-29	2004-03-18	V. I. TECHNOLOGIES, Inc.	Methods to selectively inactivate parasites in biological compositions
US20040048235A1 (en) *	1995-08-29	2004-03-11	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
GB9622159D0 (en) *	1996-10-24	1996-12-18	Solvay Sociutu Anonyme	Polyanionic polymers as adjuvants for mucosal immunization
US6093564A (en) *	1997-10-03	2000-07-25	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
US6369048B1 (en)	1998-01-12	2002-04-09	V.I. Technologies, Inc.	Methods and compositions for inactivating viruses
FR2775601B1 (fr)	1998-03-03	2001-09-21	Merial Sas	Vaccins vivants recombines et adjuves
US6617100B2 (en)	1998-09-25	2003-09-09	V.I. Technologies, Inc.	Solid phase quenching systems
US6150109A (en)	1999-01-25	2000-11-21	V. I. TECHNOLOGIES, Inc.	Lipophilic quenching of viral inactivating agents
US20020131958A1 (en) *	2001-01-22	2002-09-19	John Chapman	Method for purifying a biological composition
US20030129161A1 (en) *	2001-09-17	2003-07-10	Hsien-Jue Chu	Interleukin-12 as a veterinary vaccine adjuvant
US7790178B2 (en)	2002-12-19	2010-09-07	Intervet International B.V.	Trivalent vaccine with maternal anitbody transfer via the milk
HRP20050660A2 (en) *	2003-01-29	2006-02-28	Pfizer Products Inc.	Canine vaccines against bordetella bronchiseptica
US20050089533A1 (en) *	2003-01-29	2005-04-28	Joseph Frantz	Canine vaccines against Bordetella bronchiseptica
GB0315323D0 (en) *	2003-07-01	2003-08-06	Royal Veterinary College	Vaccine composition
US9023366B2 (en)	2003-07-01	2015-05-05	The Royal Veterinary College	Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
BRPI0415742A (pt) *	2003-10-23	2006-12-19	Pfizer Producs Inc	vacina para a doença periodontal
WO2006106424A2 (en) *	2005-04-07	2006-10-12	Pharmacia & Upjohn Company Llc	Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
EP2283859A3 (de) *	2005-10-26	2011-05-04	Canio Buonavoglia	Pantropisches Hundecoronavirus
US7682619B2 (en) *	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
KR101013226B1 (ko) *	2008-05-14	2011-02-10	녹십자수의약품(주)	개 바이러스성 설사병 예방용 백신
US20110110980A1 (en) *	2009-09-02	2011-05-12	Wyeth Llc	Heterlogous prime-boost immunization regimen
UY34745A (es)	2012-04-18	2013-11-29	Zoetis Llc	Vacunas y procedimientos para tratar la enfermedad de lyme en perros
US20140170180A1 (en)	2012-12-17	2014-06-19	Boehringer Ingelheim Vetmedica, Inc.	Porcine parvovirus 5a, methods of use and vaccine
US20140234354A1 (en)	2013-02-15	2014-08-21	Boehringer Ingelheim Vetmedica, Inc.	Porcine parvovirus 5b, methods of use and vaccine
US9579373B2 (en)	2013-03-15	2017-02-28	Boehringer Ingelheim Vetmedica, Inc.	Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
WO2019092027A1 (en)	2017-11-09	2019-05-16	Boehringer Ingelheim Vetmedica Gmbh	Sapelovirus immunogenic compositions and uses thereof
US20220054616A1 (en)	2019-01-04	2022-02-24	Boehringer Ingelheim Animal Health USA Inc.	Attenuated Bordetella Bronchiseptica Strains, Oral Vaccines Containing the Attenuated Strains, and Methods of Making & Use Thereof
CN109765384B (zh) *	2019-01-29	2022-11-18	北京勤邦生物技术有限公司	一种犬冠状病毒抗体荧光检测试纸条及其制备方法和应用
CN112402599B (zh) *	2019-08-23	2023-06-27	中国农业科学院特产研究所	一种犬用犬瘟热、细小病毒病二联灭活疫苗及其制备方法
AU2021358538A1 (en) *	2020-10-08	2023-05-25	Controlpoint Inc.	Methods and apparatuses for detecting respiratory infections
JPWO2022149342A1 (de) *	2021-01-06	2022-07-14

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3143474A (en) *	1962-07-30	1964-08-04	Sterling Drug Inc	Preparation of duck-embryo modified infectious canine hepatitis virus vaccine
US3704203A (en) †	1967-08-24	1972-11-28	Diamond Lab Inc	Transmissible gastroenteritis vaccines and methods of producing the same
US3652761A (en) *	1969-09-04	1972-03-28	Corning Glass Works	Immunochemical composites and antigen or antibody purification therewith
US3959251A (en) *	1970-06-25	1976-05-25	Exploaterings Aktiebolaget T.B.F.	Stabilized agar product and method for its stabilization

1984
- 1984-06-07 US US06/618,638 patent/US4567042A/en not_active Expired - Lifetime
- 1984-06-14 EP EP19890201996 patent/EP0345911B1/de not_active Expired - Lifetime
- 1984-06-14 DE DE3486293T patent/DE3486293T3/de not_active Expired - Lifetime
- 1984-06-14 DE DE3486292T patent/DE3486292T2/de not_active Expired - Lifetime
- 1984-06-14 AT AT84902632T patent/ATE50913T1/de not_active IP Right Cessation
- 1984-06-14 EP EP19890201017 patent/EP0329264B1/de not_active Expired - Lifetime
- 1984-06-14 DE DE3486495T patent/DE3486495D1/de not_active Expired - Lifetime
- 1984-06-14 WO PCT/US1984/000904 patent/WO1985000014A1/en not_active Ceased
- 1984-06-14 DE DE8484902632T patent/DE3481582D1/de not_active Expired - Lifetime
- 1984-06-14 AT AT89201996T patent/ATE280217T1/de not_active IP Right Cessation
- 1984-06-14 EP EP84902632A patent/EP0145783B2/de not_active Expired - Lifetime
- 1984-06-14 EP EP89202001A patent/EP0344872B2/de not_active Expired - Lifetime
- 1984-12-14 ES ES538588A patent/ES8604422A1/es not_active Expired
1989
- 1989-04-20 AT AT89201017T patent/ATE103181T1/de not_active IP Right Cessation
- 1989-07-31 AT AT89202001T patent/ATE103180T1/de not_active IP Right Cessation
1994
- 1994-08-18 NL NL940017C patent/NL940017I2/nl unknown

Also Published As

Publication number	Publication date
EP0145783B2 (de)	2004-01-02
DE3486495D1 (de)	2004-11-25
EP0329264B1 (de)	1994-03-23
EP0145783A4 (de)	1985-10-14
DE3486292T2 (de)	1994-06-30
EP0329264A3 (en)	1989-12-13
NL940017I2 (nl)	2001-02-01
DE3486293T4 (de)	1995-06-14
NL940017I1 (nl)	1994-10-17
EP0344872B2 (de)	2002-04-24
ATE280217T1 (de)	2004-11-15
DE3481582D1 (de)	1990-04-19
EP0345911B1 (de)	2004-10-20
WO1985000014A1 (en)	1985-01-03
DE3486293T3 (de)	2002-11-21
EP0145783A1 (de)	1985-06-26
EP0344872A1 (de)	1989-12-06
DE3486293T2 (de)	1994-06-30
EP0345911A1 (de)	1989-12-13
ATE103181T1 (de)	1994-04-15
ES538588A0 (es)	1986-02-01
ES8604422A1 (es)	1986-02-01
DE3486293D1 (de)	1994-04-28
DE3486292D1 (de)	1994-04-28
US4567042A (en)	1986-01-28
EP0145783B1 (de)	1990-03-14
EP0344872B1 (de)	1994-03-23
EP0329264A2 (de)	1989-08-23
ATE50913T1 (de)	1990-03-15

Legal Events

Date

Code

Title

Description

1995-01-15

UEP

Publication of translation of european patent specification

2003-03-15

UEP

Publication of translation of european patent specification

Ref document number: 0344872

Country of ref document: EP

2004-09-15

EELA

Cancelled due to lapse of time

Publication	Publication Date	Title
DE3486293D1 (de)	1994-04-28	Impfstoff-Zubereitung.
FI870104A7 (fi)	1987-07-14	Negatiivisia, valosähköisen vastuksen omaavia koostumuksia ja menetelmiä lämmönkestävien negatiivikuvien valmistamiseksi käyttämällä niitä.
DK94884D0 (da)	1984-02-23	Selvluftende, ikke-udkernende kanylesamling
IT8222620A0 (it)	1982-07-28	Diidropiridine dotate di azione ino tropa positiva,composti,loro impiego in prodotti medicinali e procedimento per la loro preparazione
DE3586841D1 (de)	1992-12-24	Orale impfstoffe.
DE3882599D1 (de)	1993-09-02	Hundecoronavirus-impfstoff.
IL51460A0 (en)	1977-04-29	Improved live newcastle disease virus vaccines
IE802141L (en)	1981-04-16	Vaccine
NL192740B (nl)	1997-09-01	Oxadethiacefalosporinederivaat met antibacteriële werking, alsmede bereidingswijze daarvoor en antibacteriaal preparaat daaruit.
IT8348232A0 (it)	1983-05-06	Azepinoindoli, loro preparazione eloro impiego come medicamenti
KR830005871A (ko)	1983-09-14	광견병 백신의 제조방법
ATE109004T1 (de)	1994-08-15	Toleranzinduktion gegenüber einem fremdantigen.
ATE112490T1 (de)	1994-10-15	Lebende newcastle-krankheit-virus-vakzine.
SE7700652L (sv)	1977-07-24	Forfarande for framstellning av ett vaccin mot panleukopeni hos katt
DE69208854D1 (de)	1996-04-11	Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt
DK233188D0 (da)	1988-04-28	Pyrrolophenylalkanolaminer, fremgangsmaader til deres fremstilling samt deres anvendelse som ydelsesfremmende midler til dyr
KR830003909A (ko)	1983-06-30	백신의 제조방법
ZHUANG et al.	1982	Further study on hepatitis B vaccination strategy
Machimana	1987	Family disorganisation in Gazankulu with special reference to social work intervention
KR880015574U (ko)	1988-10-06	농작물 유해 조수 퇴치용 모형새
ES263765Y (es)	1983-07-16	"dispositivo para evitar y detener hemorragias odontologicas".
JPS5287221A (en)	1977-07-20	Preventive for chicken dinfections
NO891355D0 (no)	1989-03-30	Vaksinasjon mot rabis-beslektede virus.
IT8621418V0 (it)	1986-04-04	Dispositivo di ricircolo dell'acqua nei beverini per animali domestici.
ES263684Y (es)	1983-04-16	"jaula de pisos perfeccionada, para la cria y recria en avicultura".